The Lancet Neurology, ISSN 1474-4422, 2018, Volume 17, Issue 3, pp. 211 - 212
Journal Article
Brain, ISSN 0006-8950, 06/2018, Volume 141, Issue 6, pp. 1589 - 1591
Journal Article
Brain, ISSN 0006-8950, 2018, Volume 141, Issue 6, pp. 1589 - 1591
Journal Article
JAMA, ISSN 0098-7484, 06/2017, Volume 317, Issue 22, pp. 2285 - 2287
The article discusses the findings of a study to evaluate the relationship, if any, between elevated brain amyloid and subsequent cognitive decline among...
COHORT | IMPAIRMENT | DECLINE | MEDICINE, GENERAL & INTERNAL | Brain - metabolism | Cognition Disorders | Humans | Amyloid beta-Peptides - metabolism | Cognition | Alzheimer Disease | Dementia | Prevention | Pathology | Amyloidosis | Research | Alzheimer's disease | Brain | Neurodegenerative diseases | Cognitive ability | Positron emission | Brain research | Dementia disorders | Biomarkers | β-Amyloid | Alzheimers disease | Positron emission tomography | Plaques | Tracers
COHORT | IMPAIRMENT | DECLINE | MEDICINE, GENERAL & INTERNAL | Brain - metabolism | Cognition Disorders | Humans | Amyloid beta-Peptides - metabolism | Cognition | Alzheimer Disease | Dementia | Prevention | Pathology | Amyloidosis | Research | Alzheimer's disease | Brain | Neurodegenerative diseases | Cognitive ability | Positron emission | Brain research | Dementia disorders | Biomarkers | β-Amyloid | Alzheimers disease | Positron emission tomography | Plaques | Tracers
Journal Article
JAMA - Journal of the American Medical Association, ISSN 0098-7484, 06/2017, Volume 317, Issue 22, pp. 2285 - 2287
Journal Article
Alzheimer's & Dementia: The Journal of the Alzheimer's Association, ISSN 1552-5260, 07/2017, Volume 13, Issue 7, pp. P178 - P179
Journal Article
Journal of Alzheimer's Disease, ISSN 1387-2877, 06/2018, Volume 64, Issue s1, pp. S213 - S227
Increasing interest in clinical trials and clinical research settings to identify Alzheimer’s disease (AD) in the earliest stages of the disease has led to the...
Pathology | Medical research | Clinical trials | Biomarkers | Risk analysis | Alzheimer's disease | Risk factors
Pathology | Medical research | Clinical trials | Biomarkers | Risk analysis | Alzheimer's disease | Risk factors
Journal Article
Brain, ISSN 0006-8950, 06/2018, Volume 141, Issue 6, pp. 1589 - 1591
This scientific commentary refers to 'Brain properties predict proximity to symptom onset in sporadic Alzheimer's disease', by Vogel et al....
DEMENTIA | NEUROSCIENCES | CLINICAL NEUROLOGY
DEMENTIA | NEUROSCIENCES | CLINICAL NEUROLOGY
Journal Article
Alzheimer's & Dementia: The Journal of the Alzheimer's Association, ISSN 1552-5260, 07/2019, Volume 15, Issue 7, pp. P1360 - P1360
Journal Article
10.
Full Text
Atrophy subtypes in prodromal Alzheimer’s disease are associated with cognitive decline
Brain, ISSN 0006-8950, 12/2018, Volume 141, Issue 12, pp. 3443 - 3456
Abstract Alzheimer’s disease is a heterogeneous disorder. Understanding the biological basis for this heterogeneity is key for developing personalized...
Journal Article
Journal of Neurology, Neurosurgery & Psychiatry, ISSN 0022-3050, 10/2011, Volume 82, Issue 10, pp. 1149 - 1156
BackgroundThe identification of subjects with mild cognitive impairment (MCI) at high risk for Alzheimer's disease (AD) is important for prognosis and early...
Genetic Predisposition to Disease - genetics | Apolipoprotein E4 - genetics | Prognosis | Prospective Studies | Follow-Up Studies | Humans | Middle Aged | Risk Factors | Genotype | Male | Cognition Disorders - genetics | Disease Progression | Alzheimer Disease - diagnosis | Cognition Disorders - diagnosis | Likelihood Functions | Alleles | Aged, 80 and over | Mental Status Schedule | Female | Aged | Alzheimer Disease - genetics | Cohort Studies
Genetic Predisposition to Disease - genetics | Apolipoprotein E4 - genetics | Prognosis | Prospective Studies | Follow-Up Studies | Humans | Middle Aged | Risk Factors | Genotype | Male | Cognition Disorders - genetics | Disease Progression | Alzheimer Disease - diagnosis | Cognition Disorders - diagnosis | Likelihood Functions | Alleles | Aged, 80 and over | Mental Status Schedule | Female | Aged | Alzheimer Disease - genetics | Cohort Studies
Journal Article
Neurology, ISSN 0028-3878, 2019, Volume 92, Issue 23, pp. e2699 - e2705
OBJECTIVE: To identify potential predictors for outcome in individuals with mild cognitive impairment (MCI) who have reverted to normal cognition (NC)....
Journal Article
Cochrane Database of Systematic Reviews, 08/2018, Volume 2018, Issue 8
Journal Article
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, ISSN 0022-3050, 10/2011, Volume 82, Issue 10, pp. 1149 - 1156
Background The identification of subjects with mild cognitive impairment (MCI) at high risk for Alzheimer's disease (AD) is important for prognosis and early...
SYSTEMATIC REVIEWS | PHOSPHORYLATED-TAU | APOE GENOTYPE | ALZHEIMERS-DISEASE | MEMORY IMPAIRMENT | TEMPORAL-LOBE ATROPHY | CSF BIOMARKERS | QUESTIONABLE DEMENTIA | MILD COGNITIVE IMPAIRMENT | APOLIPOPROTEIN-E | SURGERY | PSYCHIATRY | CLINICAL NEUROLOGY | HEALTH-CARE
SYSTEMATIC REVIEWS | PHOSPHORYLATED-TAU | APOE GENOTYPE | ALZHEIMERS-DISEASE | MEMORY IMPAIRMENT | TEMPORAL-LOBE ATROPHY | CSF BIOMARKERS | QUESTIONABLE DEMENTIA | MILD COGNITIVE IMPAIRMENT | APOLIPOPROTEIN-E | SURGERY | PSYCHIATRY | CLINICAL NEUROLOGY | HEALTH-CARE
Journal Article
Journal of Alzheimer's Disease, ISSN 1387-2877, 2018, Volume 64, Issue 1, pp. S213 - S227
Increasing interest in clinical trials and clinical research settings to identify Alzheimer's disease (AD) in the earliest stages of the disease has led to the...
cognition | biomarkers | neuronal injury | vascular risk | diagnosis | Amyloid | clinical trials | preclinical Alzheimer's disease | prognosis | lifestyle | VASCULAR RISK-FACTORS | ELDERLY INDIVIDUALS | CSF BIOMARKERS | CEREBROSPINAL-FLUID | TAU PATHOLOGY | NEUROSCIENCES | NORMAL OLDER-ADULTS | COGNITIVE DECLINE | AMYLOID-BETA DEPOSITION | PHYSICAL-ACTIVITY | BRAIN
cognition | biomarkers | neuronal injury | vascular risk | diagnosis | Amyloid | clinical trials | preclinical Alzheimer's disease | prognosis | lifestyle | VASCULAR RISK-FACTORS | ELDERLY INDIVIDUALS | CSF BIOMARKERS | CEREBROSPINAL-FLUID | TAU PATHOLOGY | NEUROSCIENCES | NORMAL OLDER-ADULTS | COGNITIVE DECLINE | AMYLOID-BETA DEPOSITION | PHYSICAL-ACTIVITY | BRAIN
Journal Article
Journal of the American Geriatrics Society, ISSN 0002-8614, 2019
OBJECTIVES: To study the interactive effect of white matter hyperintensities (WMH) and hippocampal atrophy on cognition in the oldest old. DESIGN: Ongoing...
Journal Article
Alzheimer's & Dementia: The Journal of the Alzheimer's Association, ISSN 1552-5260, 2015, Volume 11, Issue 7, pp. P213 - P214
Journal Article
Neurobiology of Aging, ISSN 0197-4580, 06/2018, Volume 66, pp. 40 - 48
Cerebral white matter hyperintensities (WMHs) have been associated with vascular risk factors, both of which are under genetic influence. We examined in a...
White matter hyperintensities | Clinical Neurology | b_open_article_in_toll_access_journal | Monozygotic twins | Ageing | Neuroscience(all) | Developmental Biology | Vascular risk factors | Geriatrics and Gerontology
White matter hyperintensities | Clinical Neurology | b_open_article_in_toll_access_journal | Monozygotic twins | Ageing | Neuroscience(all) | Developmental Biology | Vascular risk factors | Geriatrics and Gerontology
Journal Article
Neurobiology of Aging, ISSN 0197-4580, 06/2018, Volume 66, Issue June, pp. 40 - 48
Cerebral white matter hyperintensities (WMHs) have been associated with vascular risk factors, both of which are under genetic influence. We examined in a...
White matter hyperintensities | Clinical Neurology | Monozygotic twins | Ageing | Neuroscience(all) | Developmental Biology | Vascular risk factors | Geriatrics and Gerontology
White matter hyperintensities | Clinical Neurology | Monozygotic twins | Ageing | Neuroscience(all) | Developmental Biology | Vascular risk factors | Geriatrics and Gerontology
Journal Article
Neurobiology of Aging, ISSN 0197-4580, 05/2019, Volume 77, pp. 58 - 65
Amyloid pathology in cognitively normal older adults has been associated with low memory performance and cognitive complaints, but findings are conflicting....
Clinical Neurology | Monozygotic twins | Ageing | Amyloid aggregation | Cognitive complaints | Neuroscience(all) | Memory performance | Developmental Biology | Geriatrics and Gerontology
Clinical Neurology | Monozygotic twins | Ageing | Amyloid aggregation | Cognitive complaints | Neuroscience(all) | Memory performance | Developmental Biology | Geriatrics and Gerontology
Journal Article
No results were found for your search.
Cannot display more than 1000 results, please narrow the terms of your search.